A Trial of Tandem Autologous Stem Cell Transplants +/- Post Second Autologous Transplant Maintenance Therapy Versus Single Autologous Stem Cell Transplant Followed by Matched Sibling Non-Myeloablative Allogeneic Stem Cell Transplant for Patients With Multiple Myeloma (BMT CTN Protocol 0102).
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Antineoplastics; Dexamethasone; Melphalan; Thalidomide
- Indications Multiple myeloma
- Focus Therapeutic Use
- 25 Sep 2017 Biomarkers information updated
- 06 Dec 2010 Results were presented at the 52nd Annual Meeting of the American Society of Hematology (ASH).
- 05 Dec 2010 Results were presented in an abstract at at the 52nd Annual Meeting of the American Society of Hematology (ASH).